Related Experiment Video
Updated: Jul 1, 2025
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
Published on: June 10, 2022
Advances in liposome-based delivery of RNA therapeutics for cancer treatment
Mehdi Sanati1, Amir R Afshari2, Seyed Sajad Ahmadi3
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran; Experimental and Animal Study Center, Birjand University of Medical Sciences, Birjand, Iran.
Abstract:
Liposomal drug delivery systems stand as versatile therapeutic platforms for precisely targeting related elements in cancerous tissues owing to their intrinsic passive and acquired active targeting capabilities and exceptional compatibility with physiologic environments. When the capacity of liposomes as nanocarriers is combined with the revolutionary potential of RNA therapies in affecting undruggable targets, the outcome would be promising drug candidates as game-changers in the cancer treatment arena. However, optimizing liposome composition, physicochemical properties, and surface chemistry is paramount to maximizing their pharmacokinetic and pharmacodynamic attributes. This review highlighted the potential of liposomes as nanovehicles for RNA therapeutics through a literature review and looked at the most recent preclinical and clinical advancements in utilizing liposomal RNA therapeutics for cancer management. Notably, the discovery of novel targets, advancements in liposome engineering, and organizing well-planned clinical trials would help uncover the incredible potential of these nanotherapeutics in cancer patients.
Insights
Liposomes are advanced nanocarriers for RNA therapeutics, offering targeted cancer treatment. Optimizing these liposomal RNA systems is key to developing effective cancer therapies.
Area of Science:
- Nanomedicine
- Oncology
- Drug Delivery Systems
Background:
- Liposomes offer precise targeting of cancerous tissues through passive and active mechanisms.
- RNA therapeutics hold revolutionary potential for targeting previously undruggable cancer-related elements.
- Combining liposomes with RNA therapies presents a promising avenue for novel cancer treatment strategies.
Approach:
- This review synthesizes current literature on liposomal nanovehicles for RNA therapeutics.
- It examines preclinical and clinical advancements in liposomal RNA cancer therapy.
- The focus is on optimizing liposome composition, physicochemical properties, and surface chemistry.
Key Points:
- Liposomes enhance the delivery and targeting of RNA therapeutics in cancer.
- Optimizing liposome characteristics is crucial for maximizing therapeutic efficacy.
- Advancements in liposome engineering and target discovery are vital.
Conclusions:
- Liposomal RNA therapeutics represent a significant advancement in cancer treatment.
- Further research into novel targets and well-designed clinical trials will unlock their full potential.
- These nanotherapeutics are poised to be game-changers in oncology.
More Related Videos
Related Concept Videos
02:15Experimental RNAi
02:30siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...